<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="https://hdl.handle.net/20.500.11811/823">
<title>Klinik und Poliklinik für Dermatologie und Allergologie</title>
<link>https://hdl.handle.net/20.500.11811/823</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://hdl.handle.net/20.500.11811/11002"/>
<rdf:li rdf:resource="https://hdl.handle.net/20.500.11811/991"/>
</rdf:Seq>
</items>
<dc:date>2026-04-10T21:49:16Z</dc:date>
</channel>
<item rdf:about="https://hdl.handle.net/20.500.11811/11002">
<title>Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus</title>
<link>https://hdl.handle.net/20.500.11811/11002</link>
<description>Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus
Müller, Svenja; Ständer, Sonja; Naatz, Mandy; Augustin, Matthias; Steinke, Sabine
Chronic pruritus is a prevalent interdisciplinary symptom with a strong influence on health-related quality of life. Patients need extensive diagnostics and long-term treatment. This retrospective and prospective cohort study compared routine and university-based specialized care in terms of cost-effectiveness and patient benefit. Direct medical and non-medical costs and patient-reported outcomes (PRO; pruritus intensity, quality of life, treatment needs and benefits) were assessed. Data analyses were conducted using descriptive methods and non-parametric statistical tests. A total of 300 adult patients (54.3% female) participated in the study. Six months after the treatment start in a specialized German pruritus care unit, the total costs were significantly reduced (mean total costs 686 € vs 433 € per patient per half year (total cohort); p &lt;  0.001; mean out-of-pocket costs 198 € vs 124 € per half year (total cohort), p &lt;  0.001). Pruritus intensity (numerical rating  scale 5.3 vs 3.7, p &lt; 0.001), quality of life (Dermatology Life Quality Index 8.9 vs 5.7, p &lt; 0.001) and patient benefit (Patient Benefit Index Pruritus 1.2 vs 2.1, p &lt; 0.001) improved significantly (total  cohort). The results of this study show, that treatment of chronic pruritus patients in a specialized itch centre leads to an improvement in patient  benefit and reduces the economic burden at the same time.
</description>
<dc:date>2023-04-21T00:00:00Z</dc:date>
</item>
<item rdf:about="https://hdl.handle.net/20.500.11811/991">
<title>Health and Asylum Seekers in Europe</title>
<link>https://hdl.handle.net/20.500.11811/991</link>
<description>Health and Asylum Seekers in Europe
Tourneur, Isabel; Walker, Xaviour; Wiley, Elizabeth; Mattar, Caline; Esen, Fehim; Mijaljica, Goran; Roditis, Kostas; Louis, Kostas; Murt, Ahmet; Hornung, Thorsten
</description>
<dc:date>2015-10-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
